Thrombectomy Microcatheter Patent Awarded to CFD Research Corporation

Jan. 17, 2011 - PRLog -- Thrombectomy catheters facilitate fast-acting interventional therapies to remove blood clots in arteries. CFDRC's thrombectomy microcatheter uses ultrasonic acoustic streaming to disrupt blood clots, even in arteries that are too small for existing thrombectomy catheters. The novel microcatheter was developed by a CFDRC Biomedical Technology Branch team of engineers and scientists while working on a contract awarded by the National Institutes of Health (NIH) to develop improved treatments for stroke. The technology was designed through extensive use of computer simulations. Selected designs were fabricated and demonstrated for mixing and/or cleaning in CFDRC’s Bioengineering Laboratory.

“This technology is borne out of a unique marriage of our expertise in MEMS and biomedical engineering, and has the potential to dramatically improve patient outcome. With the added benefits of simplicity – no lasers, ultrasound generators or high pressure saline pumps found in competing technologies,” stated Dr. Kapil Pant, Director of Micro & Nano Biosystems at CFDRC “we anticipate significant interest from customers and partners, and are optimistic about the future of this unique technology.”

More information can be found here:
http://www.cfdrc.com/bio/biomedical-devices/thrombectomy-...

# # #

About CFDRC:
CFDRC develops and commercializes state-of-the-art technologies (advanced analysis software, innovative designs, prototypes, and expert support services), and provides solutions for aerospace and defense, biomedical and life sciences and energy and materials technologies. CFDRC is located in Huntsville, Alabama, and has been serving federal agencies and global businesses since 1987.

Presently, CFDRC has over 45 patents (awarded or pending), and works with industry partners for their adaptation and applications. CFDRC is committed to commercialize its innovative technologies, and to support and transfer those technologies to DoD, NASA, etc and/or commercial markets. Contact: Dr. Vincent J. Harrand, Vice President, 256-726-4800.